Cormorant Asset Management, LP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 123 filers reported holding ROCKET PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cormorant Asset Management, LP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,220,500
-46.6%
450,000
-48.2%
0.54%
-44.4%
Q2 2023$17,258,089
+115897.4%
868,5500.0%0.97%
-1.3%
Q1 2023$14,878
-12.5%
868,5500.0%0.98%
-13.8%
Q4 2022$16,998
-99.9%
868,5500.0%1.14%
+17.3%
Q3 2022$13,862,000
+16.0%
868,5500.0%0.97%
+7.2%
Q2 2022$11,951,000
-13.2%
868,5500.0%0.90%
-14.6%
Q1 2022$13,775,000
-27.3%
868,5500.0%1.06%
-6.2%
Q4 2021$18,960,000
-34.5%
868,550
-10.3%
1.13%
-4.1%
Q3 2021$28,950,000
-32.5%
968,5500.0%1.18%
-19.3%
Q2 2021$42,897,000
-29.4%
968,550
-29.2%
1.46%
+7.7%
Q1 2021$60,723,000
-19.1%
1,368,5500.0%1.35%
-24.2%
Q4 2020$75,051,000
+139.9%
1,368,5500.0%1.79%
+48.5%
Q3 2020$31,285,000
+1.8%
1,368,550
-6.8%
1.20%
+2.6%
Q2 2020$30,737,000
+40.5%
1,468,550
-6.4%
1.17%
+15.3%
Q1 2020$21,881,000
-47.7%
1,568,550
-14.6%
1.02%
-39.1%
Q4 2019$41,816,000
+69.0%
1,837,269
-13.5%
1.67%
+10.8%
Q3 2019$24,742,000
-20.5%
2,123,760
+2.4%
1.51%
-15.7%
Q2 2019$31,119,000
+4.4%
2,074,595
+22.0%
1.79%
-11.3%
Q1 2019$29,818,000
+3.4%
1,700,000
-12.6%
2.02%
-13.9%
Q4 2018$28,835,000
-22.0%
1,945,659
+29.7%
2.34%
-2.5%
Q3 2018$36,946,000
+23.8%
1,500,659
-1.3%
2.40%
+8.7%
Q2 2018$29,835,000
+4.7%
1,519,890
-0.0%
2.21%
+4.0%
Q1 2018$28,498,0001,519,8912.12%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q4 2019
NameSharesValueWeighting ↓
M28 Capital Management LP 523,280$10,722,00712.30%
RTW INVESTMENTS, LP 17,687,772$362,422,4487.65%
Logos Global Management LP 1,975,000$40,467,7505.40%
ACUTA CAPITAL PARTNERS, LLC 362,000$7,417,3804.97%
New Leaf Venture Partners, L.L.C. 118,242$2,422,7793.11%
MAVERICK CAPITAL LTD 5,629,970$115,358,0852.60%
Ghost Tree Capital, LLC 295,000$6,044,5501.99%
Frazier Life Sciences Management, L.P. 1,403,013$28,747,7361.91%
Ikarian Capital, LLC 654,726$13,415,3351.61%
Boxer Capital, LLC 1,466,051$30,039,3851.60%
View complete list of ROCKET PHARMACEUTICALS INC shareholders